Raymond Kaas
IFREMER
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Raymond Kaas.
Genome Biology | 2010
Uma Maheswari; Kamel Jabbari; Jean-Louis Petit; Betina M. Porcel; Andrew E. Allen; Jean-Paul Cadoret; Alessandra De Martino; Marc Heijde; Raymond Kaas; Pascal J. Lopez; Véronique Martin-Jézéquel; Agnès Meichenin; Thomas Mock; Micaela S. Parker; Assaf Vardi; E. Virginia Armbrust; Jean Weissenbach; Michael Katinka; Chris Bowler
BackgroundDiatoms represent the predominant group of eukaryotic phytoplankton in the oceans and are responsible for around 20% of global photosynthesis. Two whole genome sequences are now available. Notwithstanding, our knowledge of diatom biology remains limited because only around half of their genes can be ascribed a function based onhomology-based methods. High throughput tools are needed, therefore, to associate functions with diatom-specific genes.ResultsWe have performed a systematic analysis of 130,000 ESTs derived from Phaeodactylum tricornutum cells grown in 16 different conditions. These include different sources of nitrogen, different concentrations of carbon dioxide, silicate and iron, and abiotic stresses such as low temperature and low salinity. Based on unbiased statistical methods, we have catalogued transcripts with similar expression profiles and identified transcripts differentially expressed in response to specific treatments. Functional annotation of these transcripts provides insights into expression patterns of genes involved in various metabolic and regulatory pathways and into the roles of novel genes with unknown functions. Specific growth conditions could be associated with enhanced gene diversity, known gene product functions, and over-representation of novel transcripts. Comparative analysis of data from the other sequenced diatom, Thalassiosira pseudonana, helped identify several unique diatom genes that are specifically regulated under particular conditions, thus facilitating studies of gene function, genome annotation and the molecular basis of species diversity.ConclusionsThe digital gene expression database represents a new resource for identifying candidate diatom-specific genes involved in processes of major ecological relevance.
Environmental Toxicology and Pharmacology | 2006
Dimitri Moreau; Christophe Tomasoni; Catherine Jacquot; Raymond Kaas; Roland Le Guédes; Jean-Paul Cadoret; Arnaud Muller-Feuga; Ioanna Kontiza; Constantinos Vagias; Vassilios Roussis; Christos Roussakis
The antiproliferative activities of several extracts from cultivated microalgae in France have been studied against bronchopulmonary and epithelial cell lines, respectively (A549, NSCLC-N6 and SRA 01/04). The algal extracts, of Diatomae (Odontella aurita, Chaetoseros sp.), as well as of Haptophyceae: Isochrisys aff. galbana, appeared as the most active among all the assayed species, expressing a broad spectrum of in vitro antiproliferative activity of well-differentiated pathologic cells such as NSCLC-N6 by terminal differentiation. Bio-guided fractionation of the above referred extracts, led us to the isolation, of the carotenoid fucoxanthin. Fucoxanthin has been structurally determined, through modern spectral means and has been studied separately for its activities.
Biotechnology and Bioengineering | 2012
Gaël Bougaran; Catherine Rouxel; Nolwenn Dubois; Raymond Kaas; Sophie Grouas; Ewa Lukomska; Jean-Rene Le Coz; Jean-Paul Cadoret
Microalgae offer a high potential for energetic lipid storage as well as high growth rates. They are therefore considered promising candidates for biofuel production, with the selection of high lipid‐producing strains a major objective in projects on the development of this technology. We developed a mutation‐selection method aimed at increasing microalgae neutral lipid productivity. A two step method, based on UVc irradiation followed by flow cytometry selection, was applied to a set of strains that had an initial high lipid content and improvement was assessed by means of Nile‐red fluorescence measurements. The method was first tested on Isochrysis affinis galbana (T‐Iso). Following a first round of mutation‐selection, the total fatty acid content had not increased significantly, being
Marine Drugs | 2011
Virginie Pasquet; Perrine Morisset; Said Ihammouine; Amandine Chepied; Lucie Aumailley; Jean-Baptiste Bérard; Benoît Serive; Raymond Kaas; Isabelle Lanneluc; Valérie Thiéry; Mathieu Lafferriere; Jean-Marie Piot; Thierry Patrice; Jean-Paul Cadoret
262\pm 21\,{\rm mgTFA}\,{\rm (gC)}^{- {\rm 1}}
Bioresource Technology | 2009
P. Vauchel; K. Leroux; Raymond Kaas; Abdellah Arhaliass; Régis Baron; Jack Legrand
for the wild type (WT) and
Bioresource Technology | 2012
Benoît Serive; Raymond Kaas; Jean-Baptiste Bérard; Virginie Pasquet; Jean-Paul Cadoret
269\pm 49\,{\rm mgTFA}\,{\rm (gC)}^{- {\rm 1}}
Aquatic Living Resources | 2003
Gaël Bougaran; Loic Le Dean; Ewa Lukomska; Raymond Kaas; Régis Baron
for the selected population (S1M1). Conversely, fatty acid distribution among the lipid classes was affected by the process, resulting in a 20% increase for the fatty acids in the neutral lipids and a 40% decrease in the phospholipids. After a second mutation‐selection step (S2M2), the total fatty acid content reached
Marine Drugs | 2013
Paul-Hubert Baudelet; Anne-Laure Gagez; Jean-Baptiste Bérard; Camille Juin; Nicolas Bridiau; Raymond Kaas; Valérie Thiéry; Jean-Paul Cadoret
409\pm 64\,{\rm mgTFA}\,{\rm (gC)}^{- {\rm 1}}
Journal of Phycology | 2008
Peggy Vauchel; Abdellah Arhaliass; Jack Legrand; Raymond Kaas; Régis Baron
with a fatty acid distribution similar to the S1M1 population. Growth rate remained unaffected by the process, resulting in a 80% increase for neutral lipid productivity. Biotechnol. Bioeng. 2012; 109: 2737–2745.
PLOS ONE | 2017
Benoît Serive; Elodie Nicolau; Jean-Baptiste Bérard; Raymond Kaas; Virginie Pasquet; Jean-Paul Cadoret; Adrianna Ianora
Dunaliella tertiolecta (DT) was chemically investigated to isolate molecules inhibiting cancer cell proliferation and inducing apoptosis in vitro. The potency to inhibit cell growth was used for the bio-guided fractionation and isolation of active compounds using chromatographic techniques. The DT dichloromethane extract exhibited a strong anti-proliferative activity on MCF-7 and LNCaP cells, and was further fractionated and sub-fractionated by RP-HPLC. High resolution mass spectrometry and spectrophotometric analysis unequivocally identified violaxanthin as the most antiproliferative molecule present in DT DCM extract. Violaxanthin purified from DT induced MCF-7 dose-dependent growth inhibition in continuous and discontinuous treatments, at concentrations as low as 0.1 μg·mL−1 (0.17 μM). Phosphatidylserine exposure, typical of early apoptosis, was observed after 48 h treatment at 8 μg·mL−1 (13.3 μM) but no DNA fragmentation, characteristic of late apoptosis steps, could be detected even after 72 h treatment at 40 μg·mL−1 (66.7 μM). Taken together, our results demonstrate the strong antiproliferative activity of violaxanthin on one human mammary cancer cell line, and suggest that studying the pharmacology of violaxanthin and pharmacomodulated derivatives on cancer cells may allow potent antiproliferative drugs to be obtained.